FTM

First Turn Management Portfolio holdings

AUM $875M
1-Year Est. Return 206.38%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+206.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$875M
AUM Growth
+$209M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$24.3M
2
+$23.2M
3
+$23.1M
4
TERN icon
Terns Pharmaceuticals
TERN
+$20.2M
5
FULC icon
Fulcrum Therapeutics
FULC
+$19.3M

Top Sells

1
+$35M
2
+$25.8M
3
+$25.5M
4
IRON icon
Disc Medicine
IRON
+$20.7M
5
AKRO
Akero Therapeutics
AKRO
+$18.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
26
Kymera Therapeutics
KYMR
$6.68B
$16.1M 1.84%
206,445
-71,281
RYTM icon
27
Rhythm Pharmaceuticals
RYTM
$6.1B
$15.7M 1.79%
+146,303
OLMA icon
28
Olema Pharmaceuticals
OLMA
$1.81B
$15.4M 1.76%
+617,714
RCUS icon
29
Arcus Biosciences
RCUS
$2.75B
$13.5M 1.54%
+565,142
IRON icon
30
Disc Medicine
IRON
$2.28B
$12.2M 1.39%
153,206
-244,487
PRAX icon
31
Praxis Precision Medicines
PRAX
$8.65B
$10.5M 1.2%
+35,749
QURE icon
32
uniQure
QURE
$663M
$7.7M 0.88%
+321,655
MLTX icon
33
MoonLake Immunotherapeutics
MLTX
$1.29B
$3.46M 0.4%
262,643
ACLX icon
34
Arcellx
ACLX
$6.61B
– –
-313,733
ADMA icon
35
ADMA Biologics
ADMA
$3.74B
– –
-808,673
AKRO
36
DELISTED
Akero Therapeutics
AKRO
– –
-397,010
ELVN icon
37
Enliven Therapeutics
ELVN
$1.74B
– –
-783,411
HROW icon
38
Harrow
HROW
$1.34B
– –
-160,234
JANX icon
39
Janux Therapeutics
JANX
$840M
– –
-639,699
MRUS
40
DELISTED
Merus
MRUS
– –
-372,022
NBIX icon
41
Neurocrine Biosciences
NBIX
$13B
– –
-181,897
1
2